Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Unchanged | 2024-09-30 | 13G | Celcuity Inc. CELC | RA CAPITAL MANAGEMENT LLC | 1,286,960 3.400% | 0 (Unchanged) | Filing History |
| 2024-11-14 5:46 pm Unchanged | 2024-09-30 | 13G | Bicycle Therapeutics plc BCYC | RA CAPITAL MANAGEMENT LLC | 2,253,000 4.700% | 0 (Unchanged) | Filing History |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | Third Harmonic Bio, Inc. THRD | RA CAPITAL MANAGEMENT LLC | 1,280,826 3.100% | -752,230 (-37.00%) | Filing History |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | Structure Therapeutics Inc. GPCR | RA CAPITAL MANAGEMENT LLC | 5,690,316 3.300% | -1,534,995 (-21.24%) | Filing History |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | Praxis Precision Medicines, Inc. PRAX | RA CAPITAL MANAGEMENT LLC | 761,955 4.300% | -473,644 (-38.33%) | Filing History |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | Ascendis Pharma A/S ASND | RA CAPITAL MANAGEMENT LLC | 9,710,428 16.100% | -396,972 (-3.93%) | Filing History |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE | RA CAPITAL MANAGEMENT LLC | 1,961,863 3.400% | -16,038 (-0.81%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | UroGen Pharma Ltd. URGN | RA CAPITAL MANAGEMENT LLC | 3,206,271 7.100% | 122,713 (+3.98%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | RA CAPITAL MANAGEMENT LLC | 10,472,375 9.990% | 7,000,269 (+201.61%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Tourmaline Bio, Inc. TRML | RA CAPITAL MANAGEMENT LLC | 2,538,925 9.900% | 493,897 (+24.15%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Tenaya Therapeutics, Inc. TNYA | RA CAPITAL MANAGEMENT LLC | 7,980,736 9.990% | 1,032,500 (+14.86%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA | RA CAPITAL MANAGEMENT LLC | 21,539,465 9.990% | 2,869,376 (+15.37%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Sera Prognostics, Inc. SERA | RA CAPITAL MANAGEMENT LLC | 3,032,808 9.400% | 985,587 (+48.14%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | RxSight, Inc. RXST | RA CAPITAL MANAGEMENT LLC | 3,916,825 9.900% | 512,540 (+15.06%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS | RA CAPITAL MANAGEMENT LLC | 766,834 1.200% | 766,834 (New Position) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | NewAmsterdam Pharma Company N.V. NAMS | RA CAPITAL MANAGEMENT LLC | 9,095,589 9.990% | 898,256 (+10.96%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Geron Corporation GERN | RA CAPITAL MANAGEMENT LLC | 63,319,553 9.990% | 8,174,051 (+14.82%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | RA CAPITAL MANAGEMENT LLC | 6,381,144 6.400% | 1,167,483 (+22.39%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS | RA CAPITAL MANAGEMENT LLC | 5,105,213 9.000% | 692,063 (+15.68%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT | RA CAPITAL MANAGEMENT LLC | 5,202,145 9.990% | 1,038,934 (+24.96%) | Filing History |